Botanical Drug Market Report 2025 (Global Edition)

Global Botanical Drug Market Report 2025 Market Size Split by Source (Single-Plant Extracts, Polyherbal Formulations, Standardized Extracts), by Form (Tablets, Capsules, Powder, Ointments, Others), by...

Botanical Drug Market Report Description

We have various report editions of Botanical Drug Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Botanical Drug Market Insights Video

Competitive Landscape of the Botanical Drug Market

The competitive landscape of the botanical drug market is characterized by a range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established medicines manufacturers, specialized botanical drug companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

May 2022: In order to treat exercise-induced diarrhea in dogs, Jaguar Health, Inc. has finished its final regulatory filing for the conditional new animal medication approval of Canalevia. (Source: https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-completes-final-regulatory-filing-conditional-new) February 2022 (Jaguar Health Inc. announced that Napo Therapeutics has received the European Medicines Agency's Small and Medium Enterprise classification.) (Source: https://jaguarhealth.gcs-web.com/news-releases/news-release-details/jaguar-health-announces-receipt-napo-therapeutics-small-and)

Top Companies Market Share in Botanical Drug Industry: (In no particular order of Rank)

• Jaguar Health
• Inc.
• GW Pharmaceuticals plc
• Medigene AG
• Ahn-Gook Pharmaceutical Co.
• Ltd.
• Bayer AG
• Devonian Health Group Inc.
• Dr. Willmar Schwabe GmbH and Co. KG
• Tsumura
• Schwabe
• Tong Ren Tang
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Botanical Drug Market

Which Region Dominates the Botanical Drug Market in 2024?

According to cognitive market research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the concerns over the negative effects of synthetic pharmaceuticals, and growing knowledge of the advantages of natural cures has led to a growing trend among customers towards natural and plant-based products. Investments in this industry have been stimulated, and trust has grown as regulatory bodies such as the FDA have begun to acknowledge and approve botanical pharmaceuticals. The FDA's 2018 approval of the cannabis-derived medication Epidiolex is one such instance.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the botanical drug market due to the botanical substances have long been used in traditional medicine in the region, including Traditional Chinese Medicine (TCM), Ayurveda in India, and Kampo in Japan. This cultural basis aids the acceptability and expansion of herbal medications. Growing consumer awareness of the advantages of natural and plant-based remedies has resulted in an increase in the market for botanical medications since these medications are thought to be safer and to have fewer adverse effects than synthetic ones.

The current report Scope analyzes Botanical Drug Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Botanical Drug Market

According to cognitive market research, the global botanical drug market size was estimated at USD 169.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 67.84million in 2024 and will grow at a compound annual growth rate (CAGR) of 38.5% from 2024 to 2031.

• According to cognitive market research, the US had a major share in the botanical drug market with a market size of USD 53.53 million in 2024 and is projected to grow at a CAGR of 38.3% during the forecast period. The nation's advancements in technology.
• The Canadian botanical drug market had a market share of USD 8.14 million in 2024 and is projected to grow at a CAGR of 39.3% during the forecast period. Canada's strict government safety rules in developing nations.
• The Mexico botanical drug market is projected to witness growth at a CAGR of 39.0% during the forecast period, with a market size of USD 6.17 million in 2024.

Europe Botanical Drug Market

According to cognitive market research, the global botanical drug market size was estimated at USD 169.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 50.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 38.8% from 2024 to 2031.

• The United Kingdom's botanical drug market had a market share of USD 8.55 million in 2024 and is projected to grow at a CAGR of 39.6% during the forecast period. In the UK, botanical drug sales witness an upswing due to the nation's rising demand for this technology.
• The France botanical drug market is projected to witness growth at a CAGR of 38.0% during the forecast period, with a market size of USD 4.68 million in 2024.
• According to cognitive market research, the German botanical drug market size was valued at USD 10.07 million in 2024 and is projected to grow at a CAGR of 39.0% during the forecast period. In Germany, Botanical Drugs surged due to the presence of major market players.
• The Italy botanical drug market is projected to witness growth at a CAGR of 38.2% during the forecast period, with a market size of USD 4.38 million in 2024.
• The Russian botanical drug market is projected to witness growth at a CAGR of 37.8% during the forecast period, with a market size of USD 7.89 million in 2024.
• The Spain botanical drug market is projected to witness growth at a CAGR of 37.9% during the forecast period with a market size of USD 4.17 million in 2024
• The Luxembourg botanical drug market is projected to witness growth at a CAGR of 38.9% during the forecast period, with a market size of USD 1.58 million in 2024.
• The Portugal botanical drug market is projected to witness growth at a CAGR of 38.6% during the forecast period, with a market size of USD 1.07 million in 2024.
• The Greece botanical drug market is projected to witness growth at a CAGR of 39.1% during the forecast period, with a market size of USD 0.61 million in 2024.
• Rest of Europe's botanical drug market is projected to witness growth at a CAGR of 37.5% during the forecast period, with a market size of USD 7.89 million in 2024.

Asia Pacific Botanical Drug Market

According to cognitive market research, the global botanical drug market size was estimated at USD 169.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 39.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 42.3% from 2024 to 2031.

• According to cognitive market research, the China botanical drug market size was valued at USD 17.55 million in 2024 and is projected to grow at a CAGR of 41.8% during the forecast period. Botanical drugs have surged in China due to the adoption of various technologies.
• The Japan botanical drug market is projected to witness growth at a CAGR of 40.8% during the forecast period, with a market size of USD 5.38 million in 2024.
• The Indian botanical drug market had a market share of USD 4.68 million in 2024 and is projected to grow at a CAGR of 44.1% during the forecast period India's supportive initiatives taken by the government.
• The South Korean botanical drug market is projected to witness growth at a CAGR of 41.4% during the forecast period, with a market size of USD 3.90 million in 2024.
• The Australian botanical drug market is projected to witness growth at a CAGR of 42.0% during the forecast period, with a market size of USD 2.03 million in 2024.
• The South East Asia botanical drug market is projected to witness growth at a CAGR of 43.3% during the forecast period, with a market size of USD 2.69 million in 2024.
• The Rest of Asia Pacific botanical drug market is projected to witness growth at a CAGR of 42.1% during the forecast period, with a market size of USD 2.77 million in 2024.

South America Botanical Drug Market

According to cognitive market research, the global botanical drug market size was estimated at USD 169.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 8.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 39.7% from 2024 to 2031. .

• According to cognitive market research, the Brazil botanical drug market size was valued at USD 3.63 million in 2024 and is projected to grow at a CAGR of 40.3% during the forecast period. Botanical drugs flourished in Brazil due to the innovation in technology.
• Argentina's botanical drug market had a market share of USD 1.42 million in 2024 and is projected to grow at a CAGR of 40.6% during the forecast period. Argentina's technological advancements augment the demand.
• Colombia's botanical drug market is projected to witness growth at a CAGR of 39.5% during the forecast period, with a market size of USD 0.75 million in 2024.
• Peru's botanical drug market is projected to witness growth at a CAGR of 39.9% during the forecast period, with a market size of USD 0.70 million in 2024.
• Chile's botanical drug market is projected to witness growth at a CAGR of 40.0% during the forecast period, with a market size of USD 0.61 million in 2024.
• The Rest of Latin America's botanical drug market is projected to witness growth at a CAGR of 38.8% during the forecast period, with a market size of USD 1.37 million in 2024.

Middle East Botanical Drug Market

According to cognitive market research, the global botanical drug market size was estimated at USD 169.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 3.39 million in 2024 and will grow at a compound annual growth rate (CAGR) of 40.0% from 2024 to 2031..

• The GCC Countries' botanical drug market is projected to witness growth at a CAGR of 40.8% during the forecast period, with a market size of USD 1.45 million in 2024. Botanical Drug sales flourish due to the presence of major market players.
• The Egypt botanical drug market is projected to witness growth at a CAGR of 40.3% during the forecast period, with a market size of USD 0.36 million in 2024.
• The South African botanical drug market is projected to witness growth at a CAGR of 41.0% during the forecast period, with a market size of USD 0.54 million in 2024. Botanical Drug sales flourish in South Africa due to technological advancements, increasing demand, and regulatory support.
• The Turkey botanical drug market is projected to witness growth at a CAGR of 39.5% during the forecast period, with a market size of USD 0.29 million in 2024.
• The Nigerian botanical drug market is projected to witness growth at a CAGR of 39.1% during the forecast period, with a market size of USD 0.36 million in 2024.
• The Rest of the MEA botanical drug market is projected to witness growth at a CAGR of 39.0% during the forecast period, with a market size of USD 0.40 million in 2024.

Botanical Drug Market Analysis

Botanical Drug Market Source Segment Analysis

According to cognitive market research, standardized extracts stand out as the dominant category over the projected period because they provide a consistent concentration of active ingredients, an essential component for guaranteeing both safety and efficacy in therapeutic use standardized extracts are the preferred option. In addition to helping to comply with legal requirements, this standardization gives consumers and healthcare professionals confidence about the product's potency and quality. Standardized extracts are also a dependable option for pharmaceutical applications due to their reproducible outcomes in clinical settings, which contributes to their market domination in the botanical drug industry.

Single-plant extracts emerge as the fastest-growing category in the botanical drug market. The main reason for this is that single-plant extracts are simpler to standardize and control, two things that are essential for adhering to global pharmaceutical standards. They are also more palatable to consumers and healthcare professionals because they typically have more concentrated and well-documented clinical studies proving their safety and efficacy.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Botanical Drug Industry. Request a Free Sample PDF!

Botanical Drug Market Form Segment Analysis

According to cognitive market research, the dominant category is tablets due to their portability and ease of use, tablets are a popular option among consumers. Their ease of storage and ability to provide an exact dosage contribute to their increasing popularity..

The fastest-growing category in the botanical drug market is capsules due to customers that prefer a simple method of taking their vitamins or prescriptions like capsules since they are easy to use and provide exact amounts. It is possible to create capsules with controlled release, which increases the botanical ingredients' bioavailability and facilitates more efficient distribution and absorption by the body.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Botanical Drug Application Segment Analysis

Botanical Drug Market Application Segment Analysis

According to cognitive market research, the dominant category is oncology due to there is a global need for safer and more effective treatment alternatives due to the increasing frequency of different types of cancer. In cancer, botanical medications are gaining popularity since they are frequently thought to have fewer adverse effects than conventional chemotherapy.

The fastest-growing category in the botanical drug market is chronic disease management due to chronic diseases, including diabetes, heart disease, and arthritis, which are becoming more commonplace worldwide. Since botanical medications have natural sources and are thought to have fewer negative effects, they are frequently viewed as supplementary or alternative treatments.

• Oncology
• Dermatology
• Chronic Disease Management
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion